arrow
K

Karine Alcala

world health organization
H指数:11
被引数:899

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Systematic assessment of obesity-related risk factors in renal cancer etiology: A longitudinal risk and mendelian randomization analysis

肥胖相关风险因素在肾癌病因学中的系统性评估:一项纵向风险和孟德尔随机化分析

2026-02-011
PRE
Regular use of pharmaceutical opioids and subsequent risk of cancer: a prospective cohort study and Mendelian randomization analysis

阿片类药物的常规使用与后续癌症风险:一项前瞻性队列研究及孟德尔随机化分析

2025-11-110
OAAI
Association between socioeconomic position and lung cancer incidence in 16 countries: a prospective cohort consortium study

社会经济地位与16个国家肺癌发病率之间的关联:一项前瞻性队列联盟研究

2025-04-010
PRE
Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools

与现有预测工具相比,诊断前蛋白质组学测量的肺癌风险区分

2023-06-016
OAAI
The blood proteome of imminent lung cancer diagnosis
2023-06-0121
OAAI
Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis
2023-06-011
OAAI
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program
2023-01-0118
OAAI
The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium
2021-09-2019
OAAI
Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom (Apr, 10.1038/s41416-021-01278-0, 2021)

在英国定义肺筛查资格的肺癌风险模型的比较性能 (4月,10.1038/s41416-021-01278-0,2021)

2021-05-171
OAAI
Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions
2019-10-0150
OAAI
Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3)
2019-07-2223
OAAI